Efficacy and safety of <sup>225</sup>Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients.

Theranostics · 2020 · PMC7415797 · PMID 32802197

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

However, the difference in response was marginally significant (P-0.061), probably due to a small number of patients in each subgroup.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.